Revenue
-
Net Income
-$183.8M
▼ 69.1% YoY
EPS
$-2.06
▼ 33.8% YoY
Cash
$257.8M
▼ 5.8% YoY
FY 2025 · As of 2025-12-31
Last 90 days
| Insider | Type | Date | Shares | Price | Value | |
|---|---|---|---|---|---|---|
Barrow Robert Chief Executive Officer | Grant | Aug 12, 2026 | 375.0K | $0.00 | $0 | Form 4 ↗ |
Karlin Daniel Chief Medical Officer | Grant | Aug 12, 2026 | 100.0K | $0.00 | $0 | Form 4 ↗ |
Sullivan Mark Chief Legal Officer | Grant | Aug 12, 2026 | 62.5K | $0.00 | $0 | Form 4 ↗ |
Wiley Matthew T. Chief Commercial Officer | Grant | Aug 12, 2026 | 62.5K | $0.00 | $0 | Form 4 ↗ |
Roberts Brandi Chief Financial Officer | Grant | Aug 12, 2026 | 62.5K | $0.00 | $0 | Form 4 ↗ |
Sullivan Mark Chief Legal Officer | Sell | Jun 25, 2026 | 13.0K | $45.03 | $586K | Form 4 ↗ |
Roberts Brandi Chief Financial Officer | Sell | Jun 25, 2026 | 3.0K | $45.03 | $136K | Form 4 ↗ |
Barrow Robert Chief Executive Officer | Sell | Jun 25, 2026 | 29.2K | $45.03 | $1.32M | Form 4 ↗ |
Karlin Daniel Chief Medical Officer | Sell | Jun 25, 2026 | 10.0K | $45.03 | $452K | Form 4 ↗ |
Wiley Matthew T. Chief Commercial Officer | Sell | Jun 25, 2026 | 2.9K | $45.03 | $129K | Form 4 ↗ |
Wiley Matthew T. Chief Commercial Officer | Grant | Jun 22, 2026 | 62.5K | $0.00 | $0 | Form 4 ↗ |
Barrow Robert Chief Executive Officer | Grant | Jun 22, 2026 | 375.0K | $0.00 | $0 | Form 4 ↗ |